Florid Cemento-Osseous Dysplasia at the Site of Previous Teeth Extraction: Report of a Case

Objective: Florid cemento-osseous dysplasia (FCOD) is a rare bone lesion that predominantly involves the women’s jaws in middle age. This condition is usually asymptomatic and has a benign course.Case: This paper presents a rare case of FCOD in a white middle aged woman, which had affected mandible bilaterally and was diagnosed after tooth extraction and treated conservatively.We believed tooth extraction was a contributing factor for outbreak of such a lesion in this susceptible patient.Conclusion: For the asymptomatic patients, the best management consists of regular recall examinations with prophylaxis and reinforcement of oral hygiene to prevent periodontal diseases and tooth loss, but with accession of clinical signs and symptoms, surgical intervention is inevitable

Predkliničke studije [61Cu]ATSM kao PET radiofarmaka za snimanje fibrosarkoma

[61Cu]diacetyl-bis(N4-methylthiosemicarbazone) ([61Cu]ATSM) was prepared using in house-made diacetyl-bis(N4-methylthiosemicarbazone) (ATSM) ligand and [61Cu]CuCl2 produced via the natZn(p,x)61Cu (180 μA proton irradiation, 22 MeV, 3.2 h) and purified by a ion chromatography method. [61Cu]ATSM radiochemical purity was >98%, as shown by HPLC and RTLC methods. [61Cu]ATSM was administered into normal and tumor bearing rodents for up to 210 minutes, followed by biodistribution and co-incidence imaging studies. Significant tumor/non-tumor accumulation was observed either by animal sacrification or imaging. [61Cu]ATSM is a positron emission tomography (PET) radiotracer for tumor hypoxia imaging.[61Cu]diacetil-bis(N4-metiltiosemikarbazon) ([61Cu]ATSM) dobiven je iz liganda diacetil-bis(N4-metiltiosemikarbazona) (ATSM) pripravljenog u vlastitom laboratoriju i [61Cu]CuCl2 dobivenog iz natZn(p,x)61Cu (180 μA protonskim zračenjem, 22 MeV, 3.2 h). [61Cu]ATSM je čišćen ionskom kromatografijom. Prema HPLC i RTLC radiokemijska čistoća bila je > 98%. [61Cu]ATSM je davan zdravim glodavcima i glodavcima s tumorom tijekom 210 minuta te je praćena biodistribucija. Žrtvovanjem testiranih životinja te snimanjem primijećena je značajna razlika u akumulaciji [61Cu]ATSM u tumorskom tkivu u odnosu na zdravo tkivo. [61Cu]ATSM je pogodan za dijagnostiku hipoksije tumora pozitron emisijskom tomografijom (PET)

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378–521), affecting 3·40 billion (3·20–3·62) individuals (43·1%, 40·5–45·9 of the global population); global DALY counts attributed to these conditions increased by 18·2% (8·7–26·7) between 1990 and 2021. Age-standardised rates of deaths per 100 000 people attributed to these conditions decreased from 1990 to 2021 by 33·6% (27·6–38·8), and age-standardised rates of DALYs attributed to these conditions decreased by 27·0% (21·5–32·4). Age-standardised prevalence was almost stable, with a change of 1·5% (0·7–2·4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed

Measuring breast motion at multiple DBT compression levels using ultrasound speckle-tracking techniques

© 2018 SPIE. The goal of this study is to investigate whether reduced breast compression in digital breast tomosynthesis (DBT) exams causes larger internal breast motion that would adversely affect DBT image quality. We designed an experiment to collect real-time breast motion data from patients using ultrasound under three levels of DBT compression (full, medium and half). The ultrasound RF data had a pixel size of 21.5 μm and 150 μm in the axial and lateral directions of the probe, allowing the tracking of very fine movement of internal structure. We have successfully collected data from six human subjects and continue to recruit patients. The data were analyzed using speckle-tracking techniques to extract internal tissue movement trajectories pixel by pixel at multiple locations. Initial data analysis showed that internal breast tissue movement is highly correlated with breathing. Based on the first four patient datasets we have processed, the internal motion magnitudes on average were smaller than 1 mm under the full and reduced compression levels. The statistical distributions of the motion magnitudes among the three compression levels were similar, indicating that the internal breast motion may not necessarily increase even when compression is reduced by half. However, more data will be collected and analyzed to strengthen this study for more solid conclusions

Proprioceptive Sonomyographic Control: A novel method for intuitive and proportional control of multiple degrees-of-freedom for individuals with upper extremity limb loss

Technological advances in multi-articulated prosthetic hands have outpaced the development of methods to intuitively control these devices. In fact, prosthetic users often cite "difficulty of use" as a key contributing factor for abandoning their prostheses. To overcome the limitations of the currently pervasive myoelectric control strategies, namely unintuitive proportional control of multiple degrees-of-freedom, we propose a novel approach: proprioceptive sonomyographic control. Unlike myoelectric control strategies which measure electrical activation of muscles and use the extracted signals to determine the velocity of an end-effector; our sonomyography-based strategy measures mechanical muscle deformation directly with ultrasound and uses the extracted signals to proportionally control the position of an end-effector. Therefore, our sonomyography-based control is congruent with a prosthetic user's innate proprioception of muscle deformation in the residual limb. In this work, we evaluated proprioceptive sonomyographic control with 5 prosthetic users and 5 able-bodied participants in a virtual target achievement and holding task for 5 different hand motions. We observed that with limited training, the performance of prosthetic users was comparable to that of able-bodied participants and thus conclude that proprioceptive sonomyographic control is a robust and intuitive prosthetic control strategy

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

International audienc